Magnetically responsive smart nanoparticles for cancer treatment with a combination of magnetic hyperthermia and remote-control drug release

Theranostics

Volumn 4, Issue 8, 2014, Pages 834-844

  Hayashi, Koichiro ^a,e   Nakamura, Michihiro ^a   Miki, Hirokazu ^b   Ozaki, Shuji ^c   Abe, Masahiro ^d   Matsumoto, Toshio ^d   Sakamoto, Wataru ^e   Yogo, Toshinobu ^e   Ishimura, Kazunori ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b TOKUSHIMA UNIVERSITY HOSPITAL   (Japan)

^c TOKUSHIMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^d UNIVERSITY OF TOKUSHIMA   (Japan)

^e NAGOYA UNIVERSITY   (Japan)

Author keywords

Alternating current magnetic field; Cancer cells; Smart nanoparticles

Indexed keywords

CARBOXYLIC POLYPYRROLE; DOXORUBICIN; DRUG CARRIER; FERUCARBOTRAN; FOLIC ACID; IRON OXIDE DOXORUBICIN PYRROLE 3 CARBOXYLIC ACID POLYETHYLENE GLYCOL FOLIC ACID NANOPARTICLE; MACROGOL; MAGNETIC NANOPARTICLE; POLYPYRROLE; POLYVINYL ALCOHOL; UNCLASSIFIED DRUG; NANOPARTICLE;

ALTERNATING CURRENT MAGNETIC FIELD; AMIDATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANCER PREVENTION; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG SYNTHESIS; FEMALE; GLASS TRANSITION TEMPERATURE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; IN VIVO STUDY; MAGNETIC FIELD; MAGNETIC HYPERTHERMIA; MOLECULAR INTERACTION; MOUSE; MULTIPLE MYELOMA; NONHUMAN; OUTCOME ASSESSMENT; PARTICLE SIZE; PHARMACOLOGICAL PARAMETERS; SPECIFIC ABSORPTION RATE; STRUCTURE ACTIVITY RELATION; SURVIVAL RATE; THERMOGRAVIMETRY; TRANSMISSION ELECTRON MICROSCOPY; TUMOR VOLUME; X RAY DIFFRACTION; ANIMAL; BODY WEIGHT; DRUG RELEASE; MAGNETISM; NEOPLASMS; ORGAN SIZE; PROCEDURES; TELEMEDICINE;

ANIMALS; BODY WEIGHT; DRUG LIBERATION; FEMALE; HYPERTHERMIA, INDUCED; MAGNETIC PHENOMENA; MICE; NANOPARTICLES; NEOPLASMS; ORGAN SIZE; TELEMEDICINE;

EID: 84902517614     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.9199     Document Type: Article

References (55)

1. Mornet S, Vasseur S, Grasset F, Duguet E. Magnetic nanoparticle design for medical diagnosis and therapy. J Mater Chem. 2004; 14: 2161-75.
2. Cole AJ, Yang VC, David AE. Cancer theranostics: the rise of targeted magnetic nanoparticles. Trends Biotechnol. 2011; 29: 323-32.
3. Yen SK, Padmanabhan P, Selvan ST. Multifunctional iron oxide nanoparticles for diagnostics, therapy and macromolecule delivery. Theranostics. 2013; 3:986-1003.
4. Reddy LH, Arias JL, Nicolas J, Couvreur P. Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem Rev. 2012; 112: 5818-78.
5. Colombo M, Carregal-Romero S, Casula MF, Gutiérrez L, Morales MP, Böhm IB, Heverhagen JT, Prosperi D, Parak WJ. Biological applications of magnetic nanoparticles. Chem Soc Rev. 2012; 41: 4306-34.
6. Saldívar-Ramírez MMG, Sánchez-Torres CG, Cortés-Hernández DA, Escobedo-Bocardo JC, Almanza-Robles JM, Larson A, Reséndiz-Hernández PJ, Acuña-Gutiérrez IO. Study on the efficiency of nanosized magnetite and mixed ferrites in magnetic hyperthermia. J Mater Sci: Mater Med. 2014; DOI 10.1007/s10856-014-5187-3.
7. Jordan A, Scholz R, Wust P, Fähling H, Felix R. Magnetic fuid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles. J Magn Magn Mater. 1999; 201:413-9.
8. Guardia P, Corato RD, Lartigue L, Wilhelm C, Espinosa A, Garcia-Hernandez M, Gazeau F, Manna L, Pellegrino T. Water-soluble iron oxide nanocubes with high values of specific absorption rate for cancer cell hyperthermia treatment. ACS Nano. 2012; 6: 3080-91.
9. Klostergaard J, Seeney CE. Magnetic nanovectors for drug delivery. Nanomed -Nanotechnol Biol Med. 2012; 8: S37-50.
10. Lartigue L, Hugounenq P, Alloyeau D, Clarke SP, Lévy M, Bacri JC, Bazzi R, Brougham DF, Wilhelm C, Gazeau F. Cooperative organization in iron oxide multi-core nanoparticles potentiates their efficiency as heating mediators and MRI contrast agents. ACS Nano. 2012; 6: 10935-49.
11. Qiu P, Jensen C, Charity N, Towner R, Mao C. Oil phase evaporation-induced self-assembly of hydrophobic nanoparticles into spherical clusters with controlled surface chemistry in an oil-in-water dispersion and comparison of behaviors of individual and clustered iron oxide nanoparticles. J Am Chem Soc. 2010; 132: 17724-32.
12. Hayashi K, Nakamura M, Sakamoto W, Yogo T, Miki H, Ozaki S, Abe M, Matsumoto T, Ishimura K. Superparamagnetic nanoparticle clusters for cancer theranostics combining magnetic resonance imaging and hyperthermia treatment. Theranostics. 2013; 3: 366-76.
13. Alphandéry E, Faure S, Seksek O, Guyot F, Chebbi I. Chains of magnetosomes extracted from AMB-1 magnetotactic bacteria for application in alternative magnetic field cancer therapy. ACS Nano. 2011; 5: 6279-96.
14. Zhao Q, Wang L, Cheng R, Mao L, Arnold RD, Howerth EW, Chen ZG, Platt S. Magnetic nanoparticle-based hyperthermia for head & neck cancer in mouse models. Theranostics. 2012; 2: 113-21.
15. Bae KH, Park M, Do MJ, Lee N, Ryu JH, Kim GW, Kim CG, Park TG, Hyeon T. Chitosan Oligosaccharide-stabilized ferrimagnetic iron oxide nanocubes for magnetically modulated. ACS Nano. 2012; 6: 5266-73.
16. 4/chitosan nanocomposite for magnetic drug targeting to cancer. J Mater Chem. 2012; 22: 7622-32.
17. Brown JM, Giaccia AJ. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res. 1998; 58: 1408-16.
18. Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nat Mater. 2013; 12: 991-1003.
19. Needham D, Anyarambhatla G, Kong G, Dewhirst MW. A new temperature- sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model. Cancer Res. 2000; 60: 1197-1201.
20. Kong G, Anyarambhatla G, Petros WP, Braun RD, Colvin OM, Needham D, Dewhirst MW. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Res. 2000; 60:6950-7.
21. Meyer DE, Shin BC, Kong GA, Dewhirst MW, Chilkoti A. Drug targeting using thermally responsive polymers and local hyperthermia. J Control Release. 2001; 74: 213-24.
22. Chilkotia A, Drehera MR, Meyera DE, Raucher D. Targeted drug delivery by thermally responsive polymers. Adv Drug Deliv Rev. 2002; 54: 613-30.
23. Leal MP, Torti A, Riedinger A, Fleur RL, Petti D, Cingolani R, Bertacco R, Pellegrino T. Controlled release of doxorubicin loaded within magnetic thermoresponsive nanocarriers under magnetic and thermal actuation in a microfluidic channel. ACS Nano. 2012; 6: 10535-45.
24. Deka SR, Quarta A, Corato RD, Riedinger A, Cingolani R, Pellegrino T. Magnetic nanobeads decorated by thermo-responsive PNIPAM shell as medical platforms for the efficient delivery of doxorubicin to tumour cells. Nanoscale 2011; 3: 619-29.
25. Riedinger A, Guardia P, Curcio A, Garcia MA, Cingolani R, Manna L, Pellegrino T. Subnanometer local temperature probing and remotely controlled drug release based on azo-functionalized iron oxide nanoparticles. Nano Lett. 2013; 13: 2399-406.
26. Bonini M, Berti D, Baglioni P. Nanostructures for magnetically triggered release of drugs and biomolecules. Curr Opin Colloid Interface Sci. 2013; 18:459-67.
27. Gautier J, Allard-Vannier E, Munnier E, Soucé M, Chourpa I. Recent advances in theranostic nanocarriers of doxorubicin based on iron oxide and gold nanoparticles. J Control Release. 2013; 169: 48-61.
28. Chandra S, Barick KC, Bahadur D. Oxide and hybrid nanostructures for therapeutic applications. Adv Drug Deliv Rev. 2011; 63: 1267-81.
29. Pradhan P, Giri J, Rieken F, Koch C, Mykhaylyk O, Döblinger M, Banerjee R, Bahadur D. Plank C. Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy. J Control Release. 2010; 142: 108-21.
30. Timko BP, Kohane DS. Materials to clinical devices: technologies for remotely triggered drug delivery. Clin Ther. 2012; 34: S25-35.
31. Timko BP, Dvir T, Kohane DS. Remotely triggerable drug delivery systems. Adv Mater. 2010; 22: 4925-43.
32. Hoare T, Timko BP, Santamaria J, Goya GF, Irusta S, Lau S, Stefanescu CF, Lin D, Langer R, Kohane DS. Magnetically triggered nanocomposite membranes: a versatile platform for triggered drug release. Nano Lett. 2011; 11: 1395-400.
33. Hoare T, Santamaria J, Goya GF, Irusta S, Lin D, Lau S, Padera R, Langer R, Kohane DS. A Magnetically Triggered Composite Membrane for On-Demand Drug Delivery. Nano Lett. 2009; 9: 3651-7.
34. Ruiz-Hernández R, Baeza A, Vallet-Regí M. Smart drug delivery through DNA/magnetic nanoparticle gates. ACS Nano. 2011; 5: 1259-66.
35. Baeza A, Guisasola E, Ruiz-Hernández E, Vallet-Regí M, Chem M. Magnetically triggered multidrug release by hybrid mesoporous silica nanoparticles. Chem Mater 2012; 24: 517-24.
36. Knežević NZ, Ruiz-Hernández E, Hennink WE, Vallet-Regí M. Magnetic mesoporous silica-based core/shell nanoparticles for biomedical applications. RSC Adv. 2013; 3: 9584-93.
37. Huang HY, Hu SH, Chian CS, Chen SY, Laia HY, Chen YY. Self-assembling PVA-F127 thermosensitive nanocarriers with highly sensitive magnetically- triggered drug release for epilepsy therapy in vivo. J Mater Chem. 2012; 22:8566-73.
38. Renard PE, Jordan O, Faes A, Petri-Fink A, Hofmann H, Rüfenacht D, Bosman F, Buchegger F, Doelker E. The in vivo performance of magnetic particle- loaded injectable, in situ gelling, carriers for the delivery of local hyperthermia. Biomaterials. 2010; 31: 691-705.
39. Chen Y, Bose A, Bothun GD. Controlled release from bilayer-decorated magnetoliposomes via electromagnetic heating. ACS Nano 2010; 4: 3215-21.
40. Bothun GD, Preiss MR. Bilayer heating in magnetite nanoparticle-liposome dispersions via fluorescence anisotropy. J Colloid Interface Sci. 2011; 357: 70-4.
41. Bothun GD, Lelis A, Chen Y, Scully K, Anderson LE, Stoner MA. Multicomponent folate-targeted magnetoliposomes: design, characterization, and cellular uptake. Nanomed -Nanotechnol Biol Med. 2011; 7: 797-805.
42. Hayashi K, Ono K, Suzuki H, Sawada M, Moriya M, Sakamoto W, Yogo T. High-frequency, magnetic-field-responsive drug release from magnetic nanoparticle/organic hybrid based on hyperthermic effect. ACS Appl Mater Interfaces 2010; 2: 1903-11.
43. Hayashi K, Shimizu T, Asano H, Sakamoto W, Yogo T. Synthesis of spinel iron oxide nanoparticle/organic hybrid for hyperthermia. J Mater Res. 2008; 23:3415-24.
44. Hayashi K, Moriya M, Sakamoto W, Yogo T. Chemoselective synthesis of folic acid-functionalized magnetite nanoparticles via click chemistry for magnetic hyperthermia. Chem Mater. 2009; 21: 1318-25.
45. Hayashi K, Ono K, Suzuki H, Sawada M, Moriya M, Sakamoto W, Yogo T. One-pot biofunctionalization of magnetic nanoparticles via thiol-ene click reaction for magnetic hyperthermia and magnetic resonance imaging. Chem Mater. 2010; 22: 3768-72.
46. Yu MK, Park J, Jon S. Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics. 2012; 2: 3-44.
47. Hayashi K, Nakamura M, Miki H, Ozaki S, Abe M, Matsumoto T, Kori T, Ishimura K. Photostable iodinated silica/porphyrin hybrid nanoparticles with heavy-atom effect for wide-field photodynamic/photothermal therapy using single light source. Adv Funct Mater. 2014; 24: 503-13.
48. Hayashi K, Nakamura M, Miki H, Ozaki S, Abe M, Matsumoto T, Ishimura K. Near-infrared fluorescent silica/porphyrin hybrid nanorings for in vivo cancer imaging. Adv Funct Mater. 2012; 22: 3539-46.
49. Hayashi K, Nakamura M, Miki H, Ozaki S, Abe M, Matsumoto T, Ishimura K. Gold nanoparticle cluster-plasmon-enhanced fluorescent silica core-shell nanoparticles for x-ray computed tomography-fluorescence dual-mode imaging of tumors. Chem Commun. 2013; 49: 5334-6.
50. Silverstein RM, Webster FX, Kiemle DJ. Spectrometric Identification of Organic Compounds, 7th Ed. New York, USA: John Wiley & Sons; 2005.
51. Wu W, Xiao XH, Ren F, Zhang SF, Jiang CZ. A comparative study of the magnetic behavior of single and tubular clustered magnetite nanoparticles. J Low Temp Phys. 2012; 168: 306-13.
52. Sano K, Nakajima T, Choyke PL, Kobayashi H. Markedly Enhanced Permeability and Retention Effects Induced by Photo-immunotherapy of Tumors. ACS Nano. 2013; 7: 717-24.
53. Hong JY, Yoon H, Jang J. Kinetic study of the formation of polypyrrole nanoparticles in water-soluble polymer/metal cation systems: a light-scattering analysis. Small. 2010; 6: 679-86.
54. Hayashi K, Ono K, Suzuki H, Sawada M, Moriya M, Sakamoto W, Yogo T. Electrosprayed synthesis of red-blood-cell-like particles with dual modality for magnetic resonance and fluorescence imaging. Small. 2010; 6: 2384-91.
55. Ozaki S, Kosaka M, Wakatsuki S, Abe M, Koishihara Y, Matsumoto T. Immunotherapy of multiple myeloma with a monoclonal antibody directed against a plasma cell-specific antigen, HM1.24. Blood. 1997; 90: 3179-86.